Can-Fite Enters Warrant Exercise Deal For $4 Mln, Shares To Be Issued At Discount; Stock Plunges

Can-Fite BioPharma (CANF) announced a definitive agreement enabling the immediate exercise of certain outstanding warrants to purchase up to 1.59 million ADSs at a reduced exercise price (exact $ amount not provided in the excerpt). The action is generally supportive as it can increase near-term equity funding while diluting less than at the original exercise terms. Overall impact is likely modest for the stock given the small size and lack of detailed financial terms.